Company

Spectral Medical Inc.

Headquarters: Toronto, ON, Canada

Employees: 31

CEO: Mr. Christopher Seto

TSX: EDT -3.70%

Market Cap

C$138.3 Million

CAD as of July 1, 2024

US$100.7 Million

Market Cap History

Spectral Medical Inc. market capitalization over time

Evolution of Spectral Medical Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Spectral Medical Inc.

Detailed Description

Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Spectral Medical Inc. has the following listings and related stock indices.


Stock: TSX: EDT wb_incandescent

Stock: FSX: SD4 wb_incandescent

Stock: OTC: EDTXF wb_incandescent

Details

Headquarters:

135 The West Mall

Unit 2

Toronto, ON M9C 1C2

Canada

Phone: 416 626 3233